Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q4 EPS of ($0.26), $0.13 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $13 million versus the consensus estimate of $13.34 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.